Create a Profile
Pediatric ADHD Trial
A phase 2/3, classroom setting, randomized trial of NRCT-101SR in pediatric patients, age 13-17, with ADHD.
ADHD, also called attention-deficit disorder, is a behavior disorder, usually first diagnosed in childhood, that is characterized by inattention, impulsivity, and, in some cases, hyperactivity. These symptoms usually occur together; however, one may occur without the other(s).
The symptoms of hyperactivity, when present, are almost always apparent by the age of 7 and may be present in very young preschoolers. Inattention or attention-deficit may not be evident until a child faces the expectations of elementary school.
Eligibility Criteria:
- Children 13-17 years old
- Diagnosed with ADHD and is experiencing symptoms
- Fluent in English
Study Duration: Approximately 11-17 weeks (about 4 months), with optional open-label extension up to 6 weeks (about 1 and a half months).
Create a Profile